Business Context and Reporting Period
Company: Eastman Chemical Company
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 1997
Business Overview: Eastman operates in three primary segments: Specialty and Performance, Core Plastics, and Chemical Intermediates. The company is currently executing a global expansion program, including significant capacity additions for polyethylene terephthalate (PET).
Key Financial Metrics
| Metric (in millions, except per share) | Q1 1997 | Q1 1996 |
|---|---|---|
| Sales | $1,171 | $1,261 |
| Gross Profit | $260 | $321 |
| Gross Margin | 22.2% | 25.5% |
| Operating Earnings | $134 | $191 |
| Net Earnings | $72 | $112 |
| Net Earnings Per Share | $0.92 | $1.39 |
| Operating Cash Flow | $53 | $6 |
| Investing Cash Flow | ($189) | ($139) |
| Financing Cash Flow | $163 | $73 |
| Cash and Equivalents (End of Period) | $51 | $40 |
| Long-Term Borrowings | $1,727 | $1,523 |
| Current Ratio | 2.0x | 1.7x |
Material Changes vs. Prior Period
- Revenue Decline: Sales decreased 7% year-over-year, driven primarily by significantly lower selling prices for PET products, partially offset by moderate unit volume gains.
- Earnings Compression: Net earnings fell 36% to $72 million. The Core Plastics segment reported an operating loss of $22 million compared to $40 million in earnings the prior year, largely due to price erosion in the PET market and higher propane feedstock costs.
- Segment Performance:
- Specialty and Performance: Sales increased 1% and operating earnings rose 8% due to volume gains in coatings, inks, and resins, offsetting lower prices in specialty plastics.
- Chemical Intermediates: Sales rose 5% but operating earnings declined 13% due to lower selling prices for oxo chemicals and plasticizers.
- Cost Structure: Selling and general administrative expenses decreased 7% due to lower variable-incentive compensation. Research and development costs increased 4% due to expanded activities.
- Debt and Liquidity: Long-term borrowings increased by $204 million following the issuance of $300 million in 7.60% debentures to repay commercial paper. The current ratio improved to 2.0x.
Guidance, Outlook, and Risks
- Capital Expenditures: Total capital expenditures for 1997 are projected at approximately $850 million, focused on worldwide manufacturing capacity expansions. Depreciation is expected to be around $330 million.
- Market Outlook: Management expects continued good demand. However, Core Plastics revenues and earnings are expected to face negative comparisons in 1997 due to significant price pressure on PET from global capacity additions. Polyethylene volumes may remain constrained through Q2 1997 due to a delayed ethylene pipeline construction.
- Cost Initiatives: The "Advantaged Cost 2000" initiative targets $100 million in labor and material productivity gains for 1997 and another $100 million for 1998.
- Share Repurchases: The company does not expect significant share repurchases in 1997 due to the capital expenditure program, though it maintains a plan to repurchase up to $400 million announced in 1996.
- Risks: Key risks include continued price erosion in the PET industry, supply constraints for ethylene, and the realization of cost reduction targets. Forward-looking statements are subject to uncertainties regarding economic conditions and market trends.
Investor Verification Checklist
- PET Pricing Trends: Verify the extent of price erosion in the global PET market and its impact on the Core Plastics segment margins.
- Capital Project Timelines: Confirm the status of the delayed ethylene pipeline and the completion schedule for new PET manufacturing facilities in Europe.
- Feedstock Costs: Monitor propane and raw material cost fluctuations, which significantly impact operating earnings.
- Debt Servicing: Review the impact of increased long-term borrowings and interest rates on future cash flows.
- Volume vs. Price Mix: Assess whether volume growth in Specialty and Performance segments can sufficiently offset price declines in Core Plastics.